Contact
Three capabilities, and the limits on each

Test. Distribute. Facilitate.

Testing, distribution, and the programmes built around them. None of it involves treating a person or predicting an outcome, and each capability is defined as much by what it excludes as by what it delivers — a boundary we can hold is worth more than a promise we can't.

1Test

We pay the lab, and we don't get to pick the answer

Independent laboratories we have no stake in run identity, sterility, endotoxin and particle characterisation; we pay for the work and have no say in what comes back. Testing you cannot influence is only worth paying for if a bad result stops the shipment, so that is how we run it. The certificate of analysis travels with the material, dated to that lot rather than to a sample from last year, and it reports what was measured — never what the material is supposed to do in a person. Where the field has no validated assay for something, the certificate says so instead of leaving the line blank.

2Distribute

Research-grade, and we say so on every shipment

MSC exosomes, hTSC lines and peptides go to institutions, laboratories and licensed professionals. We do not supply the public and we do not advise on clinical use. A shipment leaves here with its batch record, its cold-chain and handling conditions, the certificate of analysis for that lot, and the name of the person here who answers for it. Receiving sites confirm in writing that they are qualified to hold the material and will use it within the rules that apply where they operate; orders outside what our written supply policy permits are declined.

3Facilitate

Programmes built on written protocol, not a handshake

Materials on their own are not research. We help clinics, universities and public-health programmes stand the work up: protocol design, sourcing, documentation standards, record-keeping and staff training, with a named Auvum scientist accountable for each engagement. Agreements are reviewed against the rules of the country the work runs in, not ours. A written standard covering what may and may not be claimed about the material is a condition of supply.

Who we work with

Clinics

For clinics and clinical investigators

We supply research materials to clinics and investigators working under the approvals that apply where they practise. Everything that leaves us arrives with its paperwork, its testing records, and a named person to call.

  • Research-grade MSC exosomes, hTSC lines, and peptides
  • Certificates of analysis from independent third-party laboratories
  • Written handling, storage, and cold-chain instructions
  • Protocol and documentation support for investigational work
  • OutPatient AI monitoring so outcomes are recorded, not guessed
Talk to our clinical team
Research partners

For research institutions

We work with universities, hospitals, and independent laboratories on sourcing, characterisation, and study design. Where a promising programme is short of materials, data, or money, we try to be the reason it keeps going.

  • Donor-specific hTSC lines and MSC-derived exosome preparations
  • Potency, identity, and release assay development
  • Investigator grants and open-access publication support
  • Shared standards for study design and data collection
  • Peptide and photobiomodulation research collaborations
Start a research conversation
Government programs

For governments and public health programmes

We work with health ministries, national research programmes, and regulators on standards, training, and engagement. The measure of success is capability that stays in the country long after we do.

  • Regulatory engagement and dossier preparation support
  • Laboratory workforce training and technical certification
  • National research programme design and site setup
  • Public health partnerships across Latin America and Asia
  • Quality standards for materials entering local research
Contact our partnerships office